Repositioning Candidate Details
| Candidate ID: | R0512 |
| Source ID: | DB11898 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | 2,4-thiazolidinedione |
| Synonyms: | |
| Molecular Formula: | C3H3NO2S |
| SMILES: | O=C1CSC(=O)N1 |
| Structure: |
|
| DrugBank Description: | Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2. |
| CAS Number: | 2295-31-0 |
| Molecular Weight: | 117.12 |
| DrugBank Indication: | |
| DrugBank Pharmacology: | |
| DrugBank MoA: | |
| Targets: | |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|